1. Becker, A. J., McCulloch, E. A., & Till, J. E. (1963). Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature, 197, 452–454.
2. Bharadwaj, A., & Glasner, P. (2009). Local cells, global science: The rise of embryonic stem cells in India. New York: Routledge.
3. Bianco, P., Barker, R., Brüstle, O., Catteneo, E., et al. (2013). Regulation of stem cell therapies under attack in Europe: For whom the bell tolls. EMBO Journal. doi:
10.1038/emboj.2013.114
.
4. BIS. (2011). Taking Stock of Regenerative Medicine in the United Kingdom, (July). UK Department of Business, Innovation and Skills (BIS) and UK Department of Health. Retrieved March 13, 2013, from
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/32459/11-1056-taking-stock-of-regenerative-medicine.pdf
.
5. Brindley, D. A., Reeve, B. C., Sahlman, W. A., Bonfiglio, W. A., Davie, N., Culme-Seymour, E., et al. (2011). The impact of market volatility on the cell therapy industry. Cell Stem Cell, 9, 397–401.